|
|
|
|
| LEADER |
01066naa a2200277 i 4500 |
| 001 |
NSK01001036671 |
| 003 |
HR-ZaNSK |
| 005 |
20190716172451.0 |
| 007 |
ta |
| 008 |
190716s2017 ci | |0|| ||eng |
| 035 |
|
|
|a (HR-ZaNSK)001036671
|
| 040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
| 042 |
|
|
|a croatica
|
| 044 |
|
|
|a ci
|c hr
|
| 080 |
1 |
|
|a 615
|2 2011
|
| 100 |
1 |
|
|a Vega Rasgado, Lourdes A.
|4 aut
|
| 245 |
1 |
0 |
|a Effect of γ-ethyl-γ-phenyl-butyrolactone (EFBL), anticonvulsant and hypnotic drug, on mouse brain catecholamine levels /
|c Lourdes A. Vega Rasgado, Iván Villanueva, Fernando Vega Díaz.
|
| 300 |
|
|
|b Ilustr.
|
| 504 |
|
|
|a Bibliografija: 28 jed.
|
| 653 |
|
0 |
|a Etil-fenil-butirolakton
|a EFBL
|a Antikonvulzivi
|a Hipnotici
|a Katekolamini
|a Mozak
|a Pokusni miševi
|
| 700 |
1 |
|
|a Villanueva, Iván
|4 aut
|
| 700 |
1 |
|
|a Vega Díaz, Fernando
|4 aut
|
| 773 |
0 |
|
|t Acta pharmaceutica (Zagreb)
|x 1330-0075
|g 67 (2017), 2 ; str. 215-226
|w nsk.(HR-ZaNSK)000054908
|
| 981 |
|
|
|b B04/17
|
| 998 |
|
|
|b milo1907
|
| 856 |
4 |
1 |
|u https://hrcak.srce.hr/172754
|y Elektronička verzija članka
|